Cargando…

EEG as a Functional Marker of Nicotine Activity: Evidence From a Pilot Study of Adults With Late-Life Depression

Late-life depression (LLD) is a debilitating condition that is associated with poor response to antidepressant medications and deficits in cognitive performance. Nicotinic cholinergic stimulation has emerged as a potentially effective candidate to improve cognitive performance in patients with cogni...

Descripción completa

Detalles Bibliográficos
Autores principales: Conley, Alexander C., Key, Alexandra P., Taylor, Warren D., Albert, Kimberly M., Boyd, Brian D., Vega, Jennifer N., Newhouse, Paul A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8732868/
https://www.ncbi.nlm.nih.gov/pubmed/35002791
http://dx.doi.org/10.3389/fpsyt.2021.721874
_version_ 1784627692673433600
author Conley, Alexander C.
Key, Alexandra P.
Taylor, Warren D.
Albert, Kimberly M.
Boyd, Brian D.
Vega, Jennifer N.
Newhouse, Paul A.
author_facet Conley, Alexander C.
Key, Alexandra P.
Taylor, Warren D.
Albert, Kimberly M.
Boyd, Brian D.
Vega, Jennifer N.
Newhouse, Paul A.
author_sort Conley, Alexander C.
collection PubMed
description Late-life depression (LLD) is a debilitating condition that is associated with poor response to antidepressant medications and deficits in cognitive performance. Nicotinic cholinergic stimulation has emerged as a potentially effective candidate to improve cognitive performance in patients with cognitive impairment. Previous studies of nicotinic stimulation in animal models and human populations with cognitive impairment led to examining potential cognitive and mood effects of nicotinic stimulation in older adults with LLD. We report results from a pilot study of transdermal nicotine in LLD testing whether nicotine treatment would enhance cognitive performance and mood. The study used electroencephalography (EEG) recordings as a tool to test for potential mechanisms underlying the effect of nicotine. Eight non-smoking participants with LLD completed EEG recordings at baseline and after 12 weeks of transdermal nicotine treatment (NCT02816138). Nicotine augmentation treatment was associated with improved performance on an auditory oddball task. Analysis of event-related oscillations showed that nicotine treatment was associated with reduced beta desynchronization at week 12 for both standard and target trials. The change in beta power on standard trials was also correlated with improvement in mood symptoms. This pilot study provides preliminary evidence for the impact of nicotine in modulating cortical activity and improving mood in depressed older adults and shows the utility of using EEG as a marker of functional engagement in nicotinic interventions in clinical geriatric patients.
format Online
Article
Text
id pubmed-8732868
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-87328682022-01-07 EEG as a Functional Marker of Nicotine Activity: Evidence From a Pilot Study of Adults With Late-Life Depression Conley, Alexander C. Key, Alexandra P. Taylor, Warren D. Albert, Kimberly M. Boyd, Brian D. Vega, Jennifer N. Newhouse, Paul A. Front Psychiatry Psychiatry Late-life depression (LLD) is a debilitating condition that is associated with poor response to antidepressant medications and deficits in cognitive performance. Nicotinic cholinergic stimulation has emerged as a potentially effective candidate to improve cognitive performance in patients with cognitive impairment. Previous studies of nicotinic stimulation in animal models and human populations with cognitive impairment led to examining potential cognitive and mood effects of nicotinic stimulation in older adults with LLD. We report results from a pilot study of transdermal nicotine in LLD testing whether nicotine treatment would enhance cognitive performance and mood. The study used electroencephalography (EEG) recordings as a tool to test for potential mechanisms underlying the effect of nicotine. Eight non-smoking participants with LLD completed EEG recordings at baseline and after 12 weeks of transdermal nicotine treatment (NCT02816138). Nicotine augmentation treatment was associated with improved performance on an auditory oddball task. Analysis of event-related oscillations showed that nicotine treatment was associated with reduced beta desynchronization at week 12 for both standard and target trials. The change in beta power on standard trials was also correlated with improvement in mood symptoms. This pilot study provides preliminary evidence for the impact of nicotine in modulating cortical activity and improving mood in depressed older adults and shows the utility of using EEG as a marker of functional engagement in nicotinic interventions in clinical geriatric patients. Frontiers Media S.A. 2021-12-23 /pmc/articles/PMC8732868/ /pubmed/35002791 http://dx.doi.org/10.3389/fpsyt.2021.721874 Text en Copyright © 2021 Conley, Key, Taylor, Albert, Boyd, Vega and Newhouse. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Psychiatry
Conley, Alexander C.
Key, Alexandra P.
Taylor, Warren D.
Albert, Kimberly M.
Boyd, Brian D.
Vega, Jennifer N.
Newhouse, Paul A.
EEG as a Functional Marker of Nicotine Activity: Evidence From a Pilot Study of Adults With Late-Life Depression
title EEG as a Functional Marker of Nicotine Activity: Evidence From a Pilot Study of Adults With Late-Life Depression
title_full EEG as a Functional Marker of Nicotine Activity: Evidence From a Pilot Study of Adults With Late-Life Depression
title_fullStr EEG as a Functional Marker of Nicotine Activity: Evidence From a Pilot Study of Adults With Late-Life Depression
title_full_unstemmed EEG as a Functional Marker of Nicotine Activity: Evidence From a Pilot Study of Adults With Late-Life Depression
title_short EEG as a Functional Marker of Nicotine Activity: Evidence From a Pilot Study of Adults With Late-Life Depression
title_sort eeg as a functional marker of nicotine activity: evidence from a pilot study of adults with late-life depression
topic Psychiatry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8732868/
https://www.ncbi.nlm.nih.gov/pubmed/35002791
http://dx.doi.org/10.3389/fpsyt.2021.721874
work_keys_str_mv AT conleyalexanderc eegasafunctionalmarkerofnicotineactivityevidencefromapilotstudyofadultswithlatelifedepression
AT keyalexandrap eegasafunctionalmarkerofnicotineactivityevidencefromapilotstudyofadultswithlatelifedepression
AT taylorwarrend eegasafunctionalmarkerofnicotineactivityevidencefromapilotstudyofadultswithlatelifedepression
AT albertkimberlym eegasafunctionalmarkerofnicotineactivityevidencefromapilotstudyofadultswithlatelifedepression
AT boydbriand eegasafunctionalmarkerofnicotineactivityevidencefromapilotstudyofadultswithlatelifedepression
AT vegajennifern eegasafunctionalmarkerofnicotineactivityevidencefromapilotstudyofadultswithlatelifedepression
AT newhousepaula eegasafunctionalmarkerofnicotineactivityevidencefromapilotstudyofadultswithlatelifedepression